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Resumo 
 A Feniletanolamina-N-metiltransferase é a enzima necessária para a conversão 
de norepinefrina (noradrenalina) em epinefrina (adrenalina). Bao et al. (2007) descreveu 
que ratinhos que não possuem esta enzima (Pnmt-KO) têm um aumento na proporção 
entre a espessura da parede posterior do ventrículo esquerdo e a dimensão interna do 
ventrículo esquerdo, mas não apresentam hipertrofia cardíaca. Os ratinhos Pnmt-KO 
apresentam, em repouso, uma pressão arterial normal mas tornam-se hipertensos 
durante o exercício físico agudo quando comparando com a estirpe selvagem (WT). O 
papel da epinefrina na resposta cardiovascular ao exercício crónico permanece pouco 
esclarecida. O objetivo deste estudo foi avaliar a morfologia cardíaca, bem como 
alterações funcionais e moleculares após o exercício crónico em animais Pnmt-KO.  
 Genotipagem por PCR foi realizada no locus da Pnmt em ratinhos Pnmt-KO 
(Pnmt-/-) e WT (Pnmt+/+). Os níveis de norepinefrina e epinefrina nas glândulas 
suprarrenais foram quantificados por RP-HPLC-ED. Os animais foram submetidos a um 
programa de exercício físico crónico durante 6 semanas. Em repouso, a pressão arterial 
foi medida após o exercício crónico. A morfologia e a função cardíaca foram avaliadas 
por ecocardiografia e hemodinâmica, seguidas de análise morfométrica. Marcadores 
moleculares de hipertrofia e fibrose cardíaca foram avaliados por PCR em tempo real. 
 Nos animais sedentários não houve diferenças na pressão arterial mas, pelo 
contrário, com o exercício crónico, um aumento da pressão arterial sistólica foi 
observado nos ratinhos Pnmt-KO em comparação com os WT. Após exercício crónico, 
foi observado um aumento do peso do coração normalizado pelo peso corporal nos 
animais Pnmt-KO comparando com os WT. A espessura da parede posterior e a massa 
do ventrículo esquerdo bem como a expressão de mRNA do IGF-1 e ANP 
apresentaram-se aumentadas e a expressão de mRNA do DDR2 não se alterou em 
animais Pnmt-KO treinados quando comparado com animais WT treinados. 
Contrariamente aos animais WT treinados, não se observaram diferenças nos 
parâmetros EF, LVEDVi e CI nos animais Pnmt-KO treinados, após perfusão com 
dobutamina.          
 Em conclusão, o aumento da pressão arterial sistólica em animais Pnmt-KO em 
resposta ao exercício crónico parece estar associada com o aumento do peso do 
coração, da espessura da parede posterior e da massa do ventrículo esquerdo bem com 
o aumento da expressão de mRNA do IGF-1 e ANP e sem diferenças na expressão de 
mRNA do DDR2, sugerindo hipertrofia concêntrica e ausência de fibrose no ventrículo 
esquerdo. A perfusão de dobutamina não levou a alterações dos parâmetros EF, 
LVEDVi e CI em animas Pnmt-KO contrariamente aos animais WT, sugerindo um 
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possível estado inicial de hipertrofia patológica concêntrica no exercício crónico em 
animais Pnmt-KO. Assim, a epinefrina parece ser essencial para a manutenção de uma 
pressão arterial normal, provavelmente através da vasodilatação induzida pelos 
recetores adrenérgicos 2, prevenindo a hipertrofia do ventrículo esquerdo durante o 
exercício crónico. 
Palavras-chave: ratinho Pnmt-KO, epinefrina, exercício crónico, pressão arterial, 
hipertrofia cardíaca. 
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Abstract 
 Phenylethanolamine-N-methyltransferase (Pnmt) is required for the conversion 
of norepinephrine (NE) to epinephrine (EPI). Bao et al. (2007) described that Pnmt-
knockout (Pnmt-KO) mice have an increased ratio of left ventricular (LV) posterior wall 
thickness to internal dimensions (LVPW/LVID), but not overall cardiac hypertrophy. 
Pnmt-KO mice showed normal resting blood pressure (BP), but became hypertensive 
during acute exercise when compared to wild-type (WT) mice. The role of EPI in 
cardiovascular response to chronic exercise remains unclear. The aim of this study was 
to evaluate cardiac morphology, and functional and molecular alterations after chronic 
exercise in Pnmt-KO mice.        
 PCR-based genotyping was performed at the Pnmt locus of Pnmt-KO (Pnmt-/-) 
and WT mice (Pnmt+/+). EPI and NE were quantified by RP-HPLC-ED, in adrenal glands. 
Animals were submitted to a 6-week exercise training program. BP was measured after 
chronic exercise, at rest. Cardiac morphology and function were evaluated by 
echocardiography and hemodynamics, followed by morphometric analysis. Molecular 
markers of cardiac hypertrophy and fibrosis were evaluated by real-time PCR.  
 There were no differences in BP between sedentary groups, however, after 
chronic exercise, Pnmt-KO mice showed a significant increase in systolic BP when 
compared with WT mice. After chronic exercise, heart weight (HW/BW) was significantly 
increased in Pnmt-KO mice when compared to WT mice. LV posterior wall thickness 
(LVPWd and LVPWs), LV mass (LVMi) and mRNA expression of IGF-1 and ANP were 
significantly increased and there were no changes in DDR2 expression in trained Pnmt-
KO mice when compared to trained WT mice. After dobutamine perfusion, trained Pnmt-
KO mice did not had any changes in EF, LVEDVi, and CI, contrary to trained WT mice. 
 In conclusion, the increased systolic BP in Pnmt-KO mice in response to chronic 
exercise appears to be associated with an increase in heart weight, LV wall thickness 
and mass and an increased IGF-1 and ANP mRNA expression and no changes in DDR2 
expression, suggesting a concentric hypertrophy and no fibrosis of the LV. Futhermore, 
dobutamine infusion did not led to any changes in EF, LVEDVi and CI in trained Pnmt-
KO, contrary to trained WT, altogether suggesting a possible initial pathological 
concentric hypertrophy stage in Pnmt-KO mice, with chronic exercise. Therefore, EPI 
appears to be essential for maintaining a normal BP, probably through 2-adrenoceptors 
induced vessel relaxation, thus preventing LV hypertrophy during chronic exercise.  
Keywords: Pnmt-KO mouse, epinephrine, chronic exercise, blood pressure, cardiac 
hypertrophy. 
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1. Introduction 
 
 1.1. Catecholamines: Historical perspective 
 Vulpian, in 1856, applied a solution of ferric chloride to slices of adrenal glands 
(AGs) and observed that the medulla stained green while the cortex did not. Also, he 
noticed that the same reaction happened in samples of venous blood leaving the adrenal, 
but not in the arterial blood entering the gland. Therefore, Vulpian assumed that the 
medulla synthesized a substance that was released into circulation (Vulpian, 1856).  
 The first pharmacological action of catecholamines was demonstrated by Oliver 
and Schäfer when they revealed that the administration of extracts of AGs led to the 
increase of blood pressure (BP) (Oliver & Schäfer, 1895). Takamine, in 1901, reported 
the first successful crystallization of a hormone named “adrenalin” (Takamine, 1901). 
Catecholamines soon became the center of various scientific discussions, with 
extraordinary breakthroughs that crossed the twentieth century (Costa, 2012). 
 
 1.2. An overview on the role of catecholamines 
 Epinephrine (EPI), norepinephrine (NE) and dopamine (DA) are known as 
catecholamines, as they have an amine side-chain, a catechol moiety, and they are all 
derived from tyrosine (Purves, 2001) (Figure 1). With 5-hydroxytryptamine, 
catecholamines share the amino side chain and altogether are known as biogenic 
amines (Purves, 2001; Costa, 2012). They form a class of hormones and chemical 
neurotransmitters that have an important role in the regulation of physiological processes 
and the development of cardiovascular, endocrine and neurological diseases. As such, 
catecholamines and the catecholamine endocrine and neuronal systems in which they 
are produced continue to have enormous research attention (Eisenhofer, Kopin, & 
Goldstein, 2004).         
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 1.2.1. Epinephrine  
 EPI (also called adrenaline), is preserved throughout vertebrate evolution and is 
an important determinant of responses to metabolic or global challenges to homeostasis 
(Bao et al., 2007; Goldstein, 2010). The chromaffin tissue in the adrenal medulla is the 
main source of this catecholamine and is present in specific parts of the brain, however 
at lower levels than the other catecholamines (Purves, 2001; Stanford, 2001). The 
synthesis of EPI is also present in several tissues outside of the adrenal medulla, such 
as heart (Axelrod, 1962) and blood vessels (Spatz et al., 1982). EPI found in other 
peripheral tissues possibly derives from uptake from the circulation (Stanford, 2001).  
EPI has positive inotropic and chronotropic actions on the heart (Furnival, Linden, 
& Snow, 1971). This catecholamine also increases oxygen consumption (Berne, 1958) 
and can cause angina pectoris (Levine, Ernstene, & Jacobson, 1930).  
 The systemic infusion of EPI has been reported to amplify increases in both BP 
and plasma NE during a cold pressor test and isometric exercise, suggesting that the 
augmented pressor responses to these stimuli are due to facilitated NE release (Vincent, 
Boomsma, Man in 't Veld, & Schalekamp, 1986). Also, the short-term administration of 
EPI seems to increase glucose and fatty acids, while high urinary EPI levels are 
associated with a favorable lipid pattern. In contrast, chronic EPI infusion enhance rat 
muscle insulin sensitivity (Jensen, Ruzzin, Jebens, Brennesvik, & Knardahl, 2005).  
 
 1.2.2. Norepinephrine  
 Von Euler was the first to show that NE (also called noradrenaline) was the main 
neurotransmitter in the sympathetic nervous system (von Euler, 1946). NE is found in 
most, but not all, postganglionic sympathetic neurons. Stimulation of sympathetic 
neurons is inseparable from the “freeze, fight or flight” response (Bracha, 2004), which 
results in the release of EPI and NE by the adrenal medulla and sympathetic neurons 
and the secretion of corticosteroids by the adrenal cortex (Wang, Xu, Gainetdinov, & 
Caron, 1999). EPI, corticosteroids and NE help to coordinate different body part 
responses for adaptation to a stressful situation (Costa, 2012) resulting in an enhanced 
energy mobilization and neural reflexes, increased heart rate (HR) and BP (Wang et al., 
1999).
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 1.2.3. Dopamine  
 DA is a neurotransmitter in cell groups in the brain and in a few peripheral groups 
(Rios et al., 1999) and is the metabolic precursor of NE and EPI (Costa, 2012) (Figure 
1). The major DA-containing area of the brain is the corpus striatum, which receives 
major input from the substantia nigra and has a significant role in the coordination of 
body movements (Purves, 2001). Also, two important central dopaminergic systems are 
located in the chemoreceptor trigger zone and in the anterior pituitary, outside the blood-
brain barrier (Costa, 2012).         
 When released, DA binds to DA receptors, present in the brain (Purves, 2001) 
and in coronary, renal, mesenteric, and intracerebral arteries (Bloom, 2006). Clinically, 
DA is used to treat shock because it dilates renal arteries by activating DA receptors and 
increases cardiac output (CO) by activating -adrenoceptors (-ARs) in the heart 
(Purves, 2001). 
 
 1.3. Biosynthesis of catecholamines 
 The various mechanisms of catecholamine synthesis, storage, release, and 
binding have been regularly studied in sympathetically innervated organs and in the 
adrenal medulla (Westfall & Westfall, 2006). The different steps that occur in the 
synthesis of DA, NE, and EPI are shown in Figure 1.     
 The biosynthetic pathway of catecholamines begins with uptake of the amino acid 
tyrosine into the cytoplasm of sympathetic neurons, adrenomedullary cells, possibly 
para-aortic enterochromaffin cells and specific centers in the brain. Circulating tyrosine 
derives from hepatic hydroxylation of phenylalanine and from the diet (Goldstein, 2010). 
The hydroxylation of tyrosine by tyrosine hydroxylase (TH) is the rate limiting step in the 
biosynthesis of catecholamines (Zigmond, Schwarzschild, & Rittenhouse, 1989). TH 
catalyzes the conversion of tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA) (Rios et 
al., 1999) and is activated after stimulation of sympathetic nerves or adrenal medulla 
(Costa, 2012). Low cerebrospinal fluid levels of NE and DA metabolites, like HVA and 3-
methoxy-4-hydroxy-phenylethylene glycol are detected in humans with TH deficiency 
(Wevers et al., 1999, Carson and Robertson, 2002). The TH knockout is unviable in mice 
as they die in the embryonic stage, maybe because catecholamine loss results in altered 
cardiac function (Zhou et al., 1995).        
 In the neuronal cytoplasm, DOPA decarboxylase (DDC), catalyzes the 
conversion of L-DOPA to DA (Goldstein, 2010). In noradrenergic neurons in the 
22 FCUP 
Role of epinephrine in cardiovascular function after chronic exercise 
 
sympathetic nervous system, in the brainstem, and in chromaffin cells, dopamine--
hydroxylase (DBH) catalysis the conversion of DA to NE (Rios et al., 1999; Goldstein, 
2010). NE deficiency (or DBH deficiency) is a rare congenital disorder (Robertson et al., 
1986; Man in't Veld, Moleman, Boomsma, & Schalekamp, 1987). NE-deficient patients 
display deficits in autonomic regulation of cardiovascular function, prompting them to 
orthostatic hypotension. Moreover, these patients show undetectable levels of NE and 
its metabolites and highly elevated DA and its metabolites (Kim et al., 2011).  
 The last step in this biosynthetic pathway is the conversion of NE to EPI by a 
cytoplasmic enzyme that requires the methyl donor S-adenosylmethionine (SAMe) as a 
cofactor, phenylethanolamine-N-methyltransferase (Pnmt) (Stanford, 2001). Pnmt is 
present in the chromaffin tissue of the adrenal medulla and in a few neuronal groups in 
the lower brainstem (Rios et al., 1999), but it is also found in the retina, brain, and heart 
(Stanford, 2001).   
          
 
Figure 1. The biosynthetic pathway of catecholamines. From Purves, Augustine et al. (2001).
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 1.4. Adrenoceptors  
 In the membranes of effector cells, adrenoceptors (ARs) determine the metabolic 
and physiological effects of catecholamines (Goldstein, 2010). The adrenoceptor family 
was first divided into two subtypes, the - and -AR as determined by pharmacological 
studies in isolated tissues (Ahlquist, 1948). The ARs are targets for many therapeutically 
drugs, including those for some cardiovascular diseases, asthma and obesity 
(Guimarães & Moura, 2001). 
 1.4.1. -Adrenoceptors  
 The -adrenoceptors (-ARs) subtypes have been classified as 1-ARs (1A-
(Schwinn et al., 1990), 1B- (Cotecchia et al., 1988; Schwinn et al., 1990) and 1D- 
(Lomasney et al., 1991; Perez, Piascik, & Graham, 1991; Bylund et al., 1994; Ford, 
Williams, Blue, & Clarke, 1994)) and 2-ARs (2A- (2D- species variation of the human 
2A-) (Bylund et al., 1992; Trendelenburg, Limberger, & Starke, 1996; Paiva, Mota, 
Moura, & Guimaraes, 1997; Guimaraes, Figueiredo, Caramona, Moura, & Paiva, 1998), 
2B- (Lomasney et al., 1990) and 2C- (Weinshank et al., 1990)).    
 Via G-protein coupled receptors, the 1-ARs mediate their response and are 
located in the central nervous system (CNS) and peripheral nervous system (PNS). In 
the CNS they are predominantly located post-synaptically where they mediate an 
excitatory role (Robinson & Hudson, 1998). Peripheral 1-ARs are located on both non-
vascular and vascular smooth muscle where activation of the receptor results in 
contraction (Aboud, Shafii, & Docherty, 1993). They are also located on the heart where 
they mediate negative or positive inotropic effects (Wang et al., 2006).  
 The 2-ARs mediate their functions through a variety of G-proteins (Robinson & 
Hudson, 1998). 2-ARs are found in both the CNS and PNS and located both pre and 
post synaptically (French, 1995). Effects of 2-ARs include the regulation of BP, 
hypothermia and cognitive function. Peripheral functions include inhibition of lipolysis 
through 2-ARs located on fat cells, hyperpolarization of sympathetic ganglia and 
contraction of vascular smooth muscle (Robinson & Hudson, 1998). 
 
 1.4.2. -Adrenoceptors  
 -adrenoceptors (-ARs) (Dixon et al., 1986) are members of the superfamily of 
G-protein-coupled receptors and have important roles in respiratory, cardiovascular, 
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reproductive, and metabolic functions (Chruscinski et al., 1999). At present, three distinct 
-ARs subtypes (1-, 2-, and 3-AR), have been identified (Dixon et al., 1986; Frielle et 
al., 1987; Emorine et al., 1989).        
 The activation of 1-ARs leads to increased HR and force of contraction (Brodde, 
1991). Although they represent a smaller population in the heart than 1-ARs, 2-ARs 
play a role in regulating cardiac function in several of species (Kaumann, 1986; Brodde, 
1991; Takei et al., 1992).         
 2-AR stimulation leads to activation of adenylyl cyclase and contributes to both 
chronotropic and inotropic responses (Brodde, 1991). -ARs also regulate peripheral 
vascular tone where the stimulation of these ARs, especially 2-ARs, in skeletal muscle, 
produces vasodilation (Goldstein, 2010). 
 
 1.5. Cardiovascular effects of Epinephrine 
 The cardiovascular effects of adrenal medullectomy in experimental animals are 
controversial, with both change and no change in HR, CO, total peripheral resistance 
and BP reported in resting dogs (Harakal, Reidenberg, Sevy, & Ohler, 1966; Ashkar, 
1971). The role of EPI has been hard to decipher because the adrenal medullectomy 
procedure can damage the adrenal cortex, altering the release of corticosteroids and it 
also removes the release of other adrenal amines and peptides, such as NE, 
chromogranin A, catestatin, and neuropeptide Y (Harrison and Seaton, 1966). 
EPI is the prototypical stress hormone and its actions are both mimicked and 
blocked by numerous commonly used medications (Ziegler, Elayan, Milic, Sun, & 
Gharaibeh, 2012).  
The administration of isoproterenol, a -AR agonist, depletes the energy reserves 
of cardiac muscle cells and causes biochemical and structural changes leading to cell 
damage and necrosis (Padmanabhan & Prince, 2006). The infusion of isoproterenol for 
7 days has been demonstrated to induce cardiac dysfunction in mice (Oudit et al., 2003). 
 Dobutamine, a 1-AR agonist, is a synthetic catecholamine that increases 
myocardial contractility, while the reflex reduction in sympathetic tone, in response to 
augmentation of stroke volume (SV), leads to a decreased total peripheral resistance 
(Vallet, Dupuis, & Chopin, 1991). Dobutamine chronotropic (HR increase) and positive 
inotropic (dP/dtmax increase) effects have been evidenced in C57BL/6 mice (Calligaris, 
Ricca, & Conget, 2013).  
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Cardiac catheterization used to measure in vivo responsiveness to dobutamine 
showed an enhancement of LV dP/dt max in mice lacking NE and EPI (dbh-/-) mice, 
suggesting increased 1-AR coupling and sensitivity to 1-agonist stimulation (Cho et al., 
1999).            
 In order to determine whether EPI plays an important role during development 
and to identify adrenergic cell descendants in the developing mouse, Ebert et al. (2004) 
inserted a Cre-recombinase gene into the mouse Pnmt locus (Pnmt-Cre). Specifically, a 
Cre-recombinase gene was inserted into exon 1, creating a gene fusion of the 5’ leader 
sequences from Pnmt directly to Cre-recombinase open reading frame. Additionally, 
germ-line transmission of the Pnmt-Cre allele was verified firstly by Southern blotting and 
then by polymerase chain reaction (PCR) (Figure 2). The nonexistence of Pnmt 
expression was predicted to result in mice that cannot produce EPI. To test this 
hypothesis, in adrenal extracts from Pnmt+/+, Pnmt+/Cre, and PnmtCre/Cre mice, the authors 
measured EPI and NE concentrations by radioimmunoassay. EPI was not detectable in 
extracts from PnmtCre/Cre mice, and the concentration of NE was found to be significantly 
greater in PnmtCre/Cre relative to Pnmt+/+ and Pnmt+/Cre extracts. In contrast, NE and EPI 
concentrations were similar in extracts from Pnmt+/+ and Pnmt+/Cre mice. All this data 
shows that insertion of Cre-recombinase into the Pnmt locus created a functional 
knockout of Pnmt expression, with loss of EPI in homozygous PnmtCre/Cre mice. Also, 
despite the reduction in Pnmt expression and EPI production in PnmtCre/Cre mice, these 
mice were viable and fertile, with no developmental defects (Ebert et al., 2004). 
 
Figure 2. Polymerase chain reaction analysis distinguishes homozygous wild-type (+/+), heterozygous mutant (+/Cre), 
and homozygous mutant (Cre/Cre) animals. From Ebert et al. (2004). 
Bao et al. (2007) also produced an EPI-deficient Pnmt-knockout (Pnmt-KO) 
mouse to further define the role of EPI in cardiovascular function. In 129/SvJ mice, a 
Cre-Neo cassette replaced the PNMT gene from the translational start codon ATG to the 
exon 3 ClaI site. Furthermore, Cre-recombinase was inserted into the PNMT 5’ 
untranslated region sequence so that its transcription was controlled by Pnmt regulatory 
elements. Germ-line transmission of the Pnmt allele was verified by Southern blot 
analysis (Figure 3) (Bao et al., 2007).        
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 EPI-deficient Pnmt-KO mice presented normal levels of NE in plasma and 
increased adrenal NE content. However, NE stimulates β2-ARs poorly compared  with 
EPI, so Pnmt-KO mice probably lacked the β2-AR induced vasodilation caused by EPI 
(Lands, Arnold, McAuliff, Luduena, & Brown, 1967; Bao et al., 2007; Sun et al., 2008; 
Moreira-Rodrigues et al., 2014)       
 During exercise, plasma EPI increases very rapidly (Tidgren, Hjemdahl, 
Theodorsson, & Nussberger, 1991) in order to decrease peripheral vascular resistance, 
lower exercise BP and enhance insulin sensitivity (Ziegler, Elayan, Milic, Sun, & 
Gharaibeh, 2012). EPI deficiency changed the cardiovascular response to acute stress 
caused by exercise. Mice with and without EPI had similar HR increases during acute 
exercise. Also, during acute exercise, Pnmt-KO mice presented a higher mean arterial 
BP (MAP) than control animals. Echocardiography under light anesthesia and during the 
stress of restraint showed that Pnmt-KO mice had an increase in the ratio of left 
ventricular posterior wall thickness to the internal dimension in diastole. During restraint, 
the left ventricular end-diastolic volume (LVEDV) was lower, causing a significantly 
smaller stroke volume (SV). As a result, CO decreased even though there was no 
change in cardiac contractility or in HR. Thus, the EPI-deficient mice had concentric 
remodeling of the left ventricle (LV) and decreased LVEDV during stress. This data 
suggests that EPI is necessary for normal BP and cardiac filling responses to acute 
stress, but is not necessary for tachycardia during stress or normal cardiovascular 
function at rest (Bao et al., 2007). 
 
 
Figure 3. The Southern blot with XbaI revealed a 15-kb band with the WT allele and an 11-kb band with the KO allele. 
WT, wild- type; HET, heterozygous Pnmt-KO; KO, homozygous Pnmt-KO mice. From Bao et al. (2007). 
 
 1.6. Cardiac hypertrophy 
 Left ventricular hypertrophy (LVH) is defined as an increase in myocardial muscle 
mass due to the increased number or size enlargement of the myocytes (Weber et al., 
1988; Gosse & Dallocchio, 1993; Messerli & Ketelhut, 1993). A compensatory 
mechanism for an increased pressure or volume load imposed on the heart is the 
FCUP 
Role of epinephrine in cardiovascular function after chronic exercise 
27 
 
hypertrophy of myocardial tissue, as it provides the mechanical adjustment necessary to 
overcome the extra burden (Panidis et al., 1984). 
 Physiological and pathological LVH are caused by different stimuli and are related 
with different molecular and structural phenotypes (McMullen & Jennings, 2007). It has 
also been shown that both physiologic and pathologic LVH may display distinct 
biochemical and molecular signaling pathways (Iemitsu et al., 2001; Heineke & 
Molkentin, 2006; Bernardo, Weeks, Pretorius, & McMullen, 2010).    
 
 1.6.1. Physiological cardiac hypertrophy  
 Exercise training is thought to produce a physiological LVH which is characterized 
by myocardial adaptations sufficient to meet increased demands while maintaining 
normal function (Colan, Sanders, & Borow, 1987; Weber, Clark, Janicki, & Shroff, 1987; 
Weber et al., 1988).         
 Physiological LVH includes different hypertrophy patterns, but these may be 
influenced by different forms of exercise training (Richey & Brown, 1998). Exercise 
increases peripheral resistance (afterload), thus stimulating concentric hypertrophy 
(Fleck, 1988; Alpert, Pape, Ward, & Rippe, 1989).      
 Structurally, exercise-induced physiological LVH can be marked by an adaptive 
growth of myocytes without fibrosis or alterations in intramural arteries frequently seen 
with hypertensive LVH (Weber et al., 1988; Vogt, Motz, Schwartzkopf, & Strauer, 1993). 
 The functional consequences of physiological LVH can be related with a normal 
diastolic function and maintenance or enhancement of contractility, capillary density and 
the mitochondrial to myocyte volume ratio (Keul, Dickhuth, Simon, & Lehmann, 1981; 
Keul, Dickhuth, Lehmann, & Staiger, 1982; Douglas, 1989).     
 After 4 weeks of treadmill exercise it has been reported that C57BL/6J mice 
developed physiological cardiac hypertrophy, confirmed by an increase in ventricular 
weights and cardiomyocyte dimensions and normal cardiac function and structure (Kemi, 
Loennechen, Wisloff, & Ellingsen, 2002). Also, an increase in heart weight to body weight 
ratio (HW/BW) has been showed after 4 weeks of voluntary wheel training (Allen et al., 
2001) and swimming exercise (Kaplan et al., 1994) in C57BL/6J mice.   
 IGF-1 is a 70-amino acid basic peptide (Rinderknecht & Humbel, 1978) which 
has growth-promoting actions on a variety of tissues including the heart (Mathews, 
Norstedt, & Palmiter, 1986; Murphy, Bell, Duckworth, & Friesen, 1987; Isgaard et al., 
1988). It has been previously reported that a significant increase in heart weight after 
IGF-1 treatment was present in rats (Lisa, Haleagrahara, & Chakravarthi, 2011). 
28 FCUP 
Role of epinephrine in cardiovascular function after chronic exercise 
 
Moreover, rats undergoing LVH by several mechanisms have an increase in IGF-1 
mRNA and protein levels within the myocardium coincident with the development of 
hypertrophy (Wahlander, Isgaard, Jennische, & Friberg, 1992; Donohue et al., 1994). 
Other reports showed that mice with constitutive overexpression of IGF-1 may develop 
an increase in heart size, characterized by both hyperplasia and cardiomyocyte 
hypertrophy, and are protected against ischemic injury and heart failure (Reiss et al., 
1996; Li et al., 1999; Kajstura et al., 2001; Yamashita et al., 2001; Welch et al., 2002). 
Activation of the IGF-1 receptor (IGF-1R) recapitulates the hypertrophic phenotype, with 
preserved contractile function and increased cardiomyocyte size (McMullen et al., 2004). 
 The reversibility of physiological LVH is a factor used to differentiate it from 
pathological LVH (Richey & Brown, 1998). The importance of exercise intensity is 
indicated by studies demonstrating that high aerobic intensity of the exercise training 
yields a larger magnitude of effects than low-to-moderate exercise intensity, including 
the cardiac hypertrophy (Kemi et al., 2002; Haram et al., 2009). No threshold intensity of 
exercise for inducing observable cardiac hypertrophy has yet been identified, but cardiac 
hypertrophy is only sustained if exercise training is maintained, and lost within weeks if 
exercise is not continued (Kemi, Haram, Wisloff, & Ellingsen, 2004). 
             
 1.6.2. Pathological cardiac hypertrophy 
  A pathological pressure overload of the LV might result from systemic 
hypertension, increased peripheral resistance, aortic stenosis or aortic coarctation. This 
pathological concentric LVH can be accompanied by a parallel addition of new myofibrils 
(wall thickening), normally with myocyte necrosis and increased fibrosis possibly leading 
to diastolic dysfunction with stiffness and decreased contractility (Richey & Brown, 1998).
  A pathological volume overload of the LV may be stimulated by such a condition 
as valvular regurgitation. Pathological eccentric LVH also suffers from increases in 
interstitial fibrosis caused by structural remodeling (Richey & Brown, 1998). In the 
ischemic or infarcted myocardium, decompensated eccentric LVH, or ventricular dilation, 
often occurs. This condition is characterized by the side-to-side slippage of myocytes in 
the affected region which may result in mechanical dysfunction (Anversa, Olivetti, & 
Capasso, 1991; Beltrami et al., 1994).  
  Pathological cardiac hypertrophy may be manifested by alterations in cardiac 
contractile proteins (α-skeletal actin and the - to β- myosin heavy chain (MHC) switch) 
and increased expression of genes such as atrial natriuretic peptide (ANP) and brain 
natriuretic peptide (BNP) (Iemitsu et al., 2001). ANP and BNP are hormones that affect 
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BP and plasma volume status through natriuretic, diuretic, and vasodilator activities 
(Woodard & Rosado, 2008). Also, they signal locally in the cardiac myocyte where they 
can antagonize hypertrophy (Kehat & Molkentin, 2010).      
  It has been demonstrated that transgenic mice overexpressing ANP have a lower 
heart weight (HW) and BP than WT mice (John et al., 1995). Moreover, low-salt 
fed ANP null mice exhibited concentric LV hypertrophy (Feng et al., 2003). Mice lacking 
the ANP receptor specifically within cardiac myocytes also showed enhanced cardiac 
hypertrophy (Holtwick et al., 2003). Taken together, these observations suggest that 
ANP plays an important role in protecting against the development of cardiac 
hypertrophy (Kehat & Molkentin, 2010). Also, in a report were physiological hypertrophy 
was induced by swimming in C57/BL6 mice, in order to exclude the occurrence of 
pathological hypertrophy, mRNA levels of ANP and BNP were determined and both 
genes were not changed in swimming mice, indicating that possibly physiological 
hypertrophy other than pathological was induced in these mice (Xiao et al., 2014).  
  The change from the to MHC phenotype is considered as a hallmark of 
pathologic hypertrophy, which is more intense in pressure-overload than in volume-
overload hypertrophy (Gupta, 2007). In animal models of pressure overload, such as 
aortic constriction in rats, rabbits and mice, the relative proportion of MHC has been 
shown to decrease during pathologic hypertrophy, but it was never found to be 
completely eliminated (Lompre et al., 1979; Mercadier et al., 1981; Litten, Martin, Low, 
& Alpert, 1982; Pillai, Russell, Raman, Jeevanandam, & Gupta, 2005).  
 The growth in fibrous tissue content is based on the maintained proliferative 
potential of fibroblasts, and the synthesis of extra-cellular matrix (ECM) proteins, 
predominantly by fibroblasts (MacKenna, Summerour, & Villarreal, 2000). Discoidin 
domain receptor 2 (DDR2) belongs to a family of collagen specific receptor tyrosine 
kinases (Shrivastava et al., 1997; Vogel, Gish, Alves, & Pawson, 1997). This receptor 
mediate a variety of cell functions, including growth, migration, morphology and 
differentiation. The tissue distribution of DDR2, a marker for cardiac fibroblasts 
(Goldsmith et al., 2004) varies, and its expression has been detected in both rat and 
mouse heart (Lai & Lemke, 1991).      
 
 1.6.3. Concentric vs Eccentric hypertrophy  
  LV remodeling and hypertrophy is determined by the type of overload. The 
commonly accepted scheme of classification of patterns of LV remodeling follows as 
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normal, concentric remodeling, concentric hypertrophy,  and eccentric hypertrophy (Lang 
et al., 2006) (Figure 4).  
 
 
Figure 4. Classification of patterns of left ventricular remodeling. Patients with normal LV mass can have either concentric 
remodeling or normal geometry and normal LV mass. Patients with increased LV mass can have either concentric or 
eccentric hypertrophy. From Lang et al. (2006). 
  The limitation of the classical categories is the suboptimal categorization of 
dilated ventricles (Khouri, Peshock, Ayers, de Lemos, & Drazner, 2010). Khouri et al. 
(2010) found that concentric or eccentric LVH may each be subclassified into 2 
subgroups, yielding 4 different geometric patterns. Also, this work suggests the 
hypothesis that the adaptation of the LV is the result of the independent increase in wall 
thickness and/or chamber dimension rather than the effect of their interaction (relative 
wall thickness (RWT)) to compensate for increased wall stress (Khouri, Peshock, Ayers, 
de Lemos, & Drazner, 2010) (Figure 5).  
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Figure 5. Representation of the 4-tiered classification of left ventricular hypertrophy (LVH).Classification may be made by 
presence or absence of LVH (horizontal axis) and by geometry (vertical axis), depending on mass-to-volume ratio. From 
Chinali & Aurigemma (2010). 
  Both concentric processes are normally in response to LV pressure overload, 
with the earliest response exhibited as concentric remodeling. This response shows 
normal or small LV cavity size, increased LV wall thickness and normal LVM (Marwick 
et al., 2015). Once the LVM is increased it is referred to as concentric hypertrophy (Lang 
et al., 2006). A concentric hypertrophy pattern may show the parallel addition of new 
myofibrils that create a thickening of the myocardial wall (Richey & Brown, 1998). This 
hypertrophic response is an attempt to limit wall stress to allow for the maintenance of 
normal LV systolic function and performance (Gaasch & Zile, 2011).  
  The increase in preload may produce an eccentric hypertrophy pattern 
characterized by the addition of new sarcomeres which results in dilated ventricular 
cavities, increased LVM and normal LV wall thickness (Marwick et al., 2015). The 
increase in chamber size produces a wall thinning effect that elevates wall stress (Richey 
& Brown, 1998). Consequently, this condition might produce a positive feedback loop 
stimulating a concentric hypertrophic response in an attempt to normalize the elevated 
wall stress (Hood, Rackley, & Rolett, 1968; Grossman et al., 1975; Alpert et al., 1989). 
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 1.7. Objectives 
  The role of EPI in normal cardiovascular function associated with chronic exercise 
training has not been fully elucidated. Nowadays, loss-of-function studies are widely 
used to clarify the role of a specific gene or protein. In that basis, the aim of this study is 
to evaluate cardiac morphological, functional and molecular alterations after chronic 
exercise training in Pnmt-KO and wild-type (WT) mice. For this purpose, it was 
established and organized a framework including i) identification of genotypes at the 
Pnmt locus by PCR analysis, ii) quantification of EPI and NE in AGs, iii) evaluation of BP 
and HR by tail-cuff method after a 6-week exercise training program, iv) evaluation of 
cardiac morphology and function by echocardiography and hemodynamics, followed by 
v) morphometric analysis and vi) evaluation of molecular markers of cardiac hypertrophy 
and fibrosis.
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2. Materials and Methods 
 
 2.1. Animals  
  All animal care and experimental procedures were performed in accordance with 
the European Directive 63/2010/EU, transposed to the Portuguese legislation by the 
Directive Law 113/2013. Ten-week-old WT (129x1/SvJ, n=38) and Pnmt-KO (129x1/SvJ, 
n=15) male mice were used for this study. The animals were kept in cages under 
controlled environmental conditions (12 hour light/dark cycle, room temperature 23 ± 
1°C, humidity 50%, autoclaved drinking water, and mice breeding diet 4RF25/I; 
Ultragene, Porto, Portugal) and housed with the respective litter. 
  
 2.2. Genotyping 
  The Pnmt-KO mice were produced by disruption of Pnmt locus by insertion of 
Cre-recombinase in exon 1 (Ebert et al., 2004). A couple of Pnmt-KO mice were kindly 
provided by Steven N. Ebert and animals were bred in our conventional vivarium. 
Genotyping was done by PCR amplification analysis of the PNMT gene in ear samples 
by using the following primers: Primer 1, 5’-CAGGCGCCTCATCCCTCAGCAGCC-3’; 
Primer 2, 5’-CTGGCCAGCGTCGGAGTCAGGGTC-3’; and Primer 3, 5’ 
GGTGTACGGTCAGTAAATTGGACACCGTCCTC-3’. 
  
 2.3. Acute exercise training protocol 
  Sedentary WT and Pnmt-KO mice were left without exercise training. The acute 
exercise training program was always performed at the same time of day. WT mice were 
adapted to the procedure 3 days before the beginning of the acute exercise training 
protocol. Before the training session, the animals were allowed 15 minutes to adapt to 
the treadmill without exercising.  Exercise training was done on a motor treadmill (Panlab 
Harvard Apparatus, Barcelona, Spain), starting at 6 cm/s for 10 minutes with an increase 
in speed of 3 cm/s every 2 minutes until 20 m/min, for 55 minutes (until exhaustion if 55 
minutes duration was not reached). It was considered exhaustion the animal’s 
permanence in the shock grid (0.2 mA) for more than 5 consecutive seconds or the third 
time that the animal stays 2 or more seconds in the shock grid (without any attempt to 
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return to the treadmill). Once the animal reached one of the two exhaustion criteria, it 
was removed from the motor treadmill. 
 
 2.4. Assay of catecholamines 
  After acute exercise training, the animals were anesthetized (ketamine, 100 
mg/kg and xylazine, 10 mg/kg, i.p.) and AGs were removed. The assay of 
catecholamines in AGs was performed by reversed-phase high-performance liquid 
chromatography with electrochemical detection (RP-HPLC-ED). In brief, catecholamines 
in 0.3 mL of perchloric acid, in which AGs had been kept, were eluted on Corning Costar 
Spin-X (Sigma-Aldrich, MO, EUA) centrifuge tube filters. After dilution and centrifugation, 
50 µL of the eluate were injected into an HPLC for separation of NE and EPI (Gilson 
Medical Electronics, Villiers le Bel, France) (Moreira-Rodrigues et al., 2014). The lower 
limit of detection ranged from 350 to 1000 fmol. 
 
 2.5. Chronic exercise training protocol 
  Sedentary WT and Pnmt-KO mice were left without exercise training. The chronic 
exercise training program was always performed at the same time of day. Pnmt-KO and 
WT mice were adapted to the procedure 3 days before the beginning of the exercise 
training protocol. Before the training session, the animals were allowed 15 minutes to 
adapt to the treadmill without exercising. Exercise training was performed on a motor 
treadmill (Panlab Harvard Apparatus, Barcelona, Spain), starting at 6 cm/s for 10 minutes 
with an increase in speed of 3 cm/s every 2 minutes until 20 m/min, for 55 minutes (until 
exhaustion if 55 minutes duration was not reached), 5 days/week for 6 weeks (Paulino 
et al., 2010). It was considered exhaustion the animal’s permanence in the shock grid 
(0.2 mA) for more than 5 consecutive seconds or the third time that the animal stays 2 
or more seconds in the shock grid (without any attempt to return to the treadmill). As 
soon as the animal reached one of the two exhaustion criteria, it was removed from the 
motor treadmill. 
 
 2.6. Blood pressure and heart rate measurements 
  Systolic (SBP) and diastolic (DBP) BP and HR were measured after 6 weeks of 
chronic exercise training in conscious restrained animals, in a temperature control box 
at 37-38oC, using a photoelectric tail-cuff pulse detector (Kent Scientific, CT, USA) 
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(Moreira-Rodrigues et al., 2010). Four determinations were made each time and the 
means were used for further analysis. 
 
 2.7. Echocardiographic and hemodynamic evaluation 
  BW was measured in WT and Pnmt-KO mice. Upon sedation and analgesia with 
50 µg/kg and 5 mg/kg intraperitoneal fentanyl and midazolam, respectively, mice were 
anesthetized by inhalation of 8% sevoflurane in vented containers, orotracheally 
intubated (20G) and mechanically ventilated using a MouseVent™ Automatic Ventilator 
(Physiosuite, Kent Scientific, CT, USA). Anesthesia was maintained with sevoflurane (1-
2.5%) titrated to avoid the toe pinch reflex. Mice were placed in left-lateral decubitus on 
a heating pad, the electrocardiogram was monitored (Animal Bio Amp, FE136, 
ADInstruments, Dunedin, New Zealand) and their temperature was automatically kept at 
38ºC using a RightTemp™ Temperature Monitor & Homeothermic Controller 
(Physiosuite, Kent Scientific, CT, USA). The peripheral oximetry (MouseSTAT™ - Pulse 
Oximeter & Heart Rate Monitor, Physiosuite, Kent Scientific, CT, USA), capnography, 
respiratory rate (RR) and minute ventilation (CapnoScan™ - End-Tidal CO2 Monitor, 
Physiosuite, Kent Scientific, CT, USA) were continuously motorized.    
  Cardiac ultrasounds were performed using an ACUSON Sequoia™ C512 
ultrasound system (Siemens Medical Solutions, CA, USA). Before applying pre-warmed 
echocardiography gel, chest was shaved and depilated and then a linear 15MHz 
ACUSON™ Sequoia 15L8W (Siemens Medical Solutions, CA, USA) probe was gently 
positioned on the thorax. The 2-D parasternal short-axis imaging plane was used as a 
guide for obtaining LV end-systolic and end-diastolic endocardial and epicardial areas 
and also wall thickness and cavity dimensions using M-mode tracings, just above the 
papillary muscle. Based on this values, LV volumes, ejection fraction (EF) and fractional 
shortening (FS) were calculated according to Teichholdz formula, and LV mass was 
determined in diastole through an uncorrected cube method (Kiatchoosakun, Restivo, 
Kirkpatrick, & Hoit, 2002). The parasternal long axis view was used to measure LV long 
axis, from the mitral annulus to LV endocardial surface at the apex, and to record aortic 
root dimensions in M-mode. Pulsed-wave (PW) Doppler velocity tracings in the 4-
chamber view allowed to assess LV filling with the peak early (E) and late (A) wave 
velocities of the mitral inflow. Peak early diastolic (E’) and systolic (S’) mitral annular 
velocities were measured with tissue Doppler (TDI) at lateral mitral annulus, and E/E’ 
ratio was calculated. All the recordings were averaged from three consecutive heartbeats  
  For the hemodynamic evaluation, the right jugular vein was catheterized (24G) 
under surgical microscopy for fluid replacement with warm Ringer’s lactate solution at 64 
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ml/Kg/h (NE-1000, New Era Pump Systems, NY, USA). After left thoracotomy, a 
pressure volume (PV) catheter (PV-1035, Millar Instruments, TX, USA), was inserted 
through the apex and signals were continuously acquired (MPVS 3000, Millar 
Instruments) and digitized at 1000 Hz (ML880 PowerLab 16/30, ADInstruments, 
Dunedin, New Zealand). Parallel conductance was assessed by 10 µL of 10% hypertonic 
saline injection. Baseline recordings were obtained after a stabilization period of 30 
minutes and inferior vena cava (IVC) occlusion with a 5-0 silk lace were also obtained to 
derive load-independent indexes of contractility and compliance by linear and 
exponential fitting of the end-systolic and end-diastolic PV relationships (ESPVR and 
EDPVR). After an intravenous infusion of dobutamine (1-AR agonist) at 5 µg/Kg/min, 
IVC occlusion recordings were repeated upon obtaining a stable effect of at least 10 
minutes. All acquisitions were performed with ventilation suspended at end-expiration. 
To account for large differences in body weight (BW) between groups, all volumes were 
indexed for body surface area (BSA) as estimated by 9.82*body weight (BW)2/3 in grams 
(Cheung et al., 2009). Upon completion of experiments, animals were euthanized by 
exsanguination under anesthesia and samples were collected. 
 
 2.8. Morphometric analysis 
  Hearts were removed, weighed and dissected. Afterwards, the LV, right ventricle 
(RV) and interventricular septum (IVS) were weighted. Gastrocnemius muscle weight 
(GW) and tibia length were also measured. The ratios between heart weight (HW/BW), 
LV weight (LVW/BW), IVS weight (IVSW/BW), RV weight (RVW/BW), GW (GW/BW) and 
BW were calculated.    
 
 2.9. Determination of plasma Brain Natriuretic Peptide 
 The levels of BNP in mice plasma were measured using the Brain Natriuretic 
Peptide Enzyme Immunoassay (EIA) Kit (Sigma-Aldrich, MO, EUA) with detectable 
levels of BNP ranging from 0.1 to 1,000 pg/mL according to the manufacturer’s 
instructions. 
 
 2.10. Total RNA isolation from left ventricular tissue  
  LV tissue samples were collected and frozen (-80°C). For tissue homogenization, 
1 mL of Trizol Reagent (Sigma-Aldrich, MO, EUA) was added to the tubes with the 
samples and the contents were transferred to MagNA Lyser Green Beads tubes, prefilled 
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with 1.4 mm-diameter ceramic beads (Roche Diagnostics, Basel, Switzerland). Then, 
tissues were homogenized using the MagNA Lyser Instrument homogenizer (Roche 
Diagnostics, Basel, Switzerland). Homogenized samples were incubated for 5 minutes 
at room temperature to allow complete dissociation of the nucleoprotein complex. 
Afterwards, 200 µL of chloroform were added, the tubes were shaken by hand for 15 
seconds, incubated for 2-3 minutes at room temperature and later centrifuged at 12,000 
×g for 15 minutes at 4°C. Samples separated into a red phenol-chloroform phase and an 
aqueous phase where the RNA remains exclusively. The aqueous phase was collected 
into a new tube, and 200µL of 95% ethanol were added to the cleared lysate.   
  After a centrifugation at 12,000 ×g for 1 minute, total RNA isolation was carried 
out with the SV Total RNA Isolation System kit (Promega, WI, USA), according to the 
manufacturer's instructions.  
  Concentration and purity of the isolated RNA was measured using the NanoDrop 
2000 spectrophotometer (Thermo Scientific, MA, USA). One µL of the eluted RNA was 
used to determine the concentration by measuring A260 absorbance for each sample. 
Purity was assessed by calculating A260/A280 and A260/A230 ratios. Nuclease-free 
water was used as blank.  
  A fraction of RNA from each sample was individually mixed with loading dye 
(Bromophenol blue 6x), loaded into a 1 %(w/v) agarose gel and ran at 90 V for 50 minutes 
using PowerPac™ Basic Power Supply (Bio-Rad, CA, USA) to assess RNA integrity. All 
samples were then stored at -70°C. 
 
 2.11. cDNA synthesis  
  Reverse transcription (20 µL) was performed in a T100™ Thermal Cycler (Bio-
Rad, CA, USA) and consisted of different steps which are described below.   
  In the first step, after mixing 1 µg of RNA, 5x Reaction Buffer (Thermo Scientific, 
MA, USA), 1.7 µM oligo (dT)18 Primer (Thermo Scientific, MA, USA), 10 U/reaction of 
Ribolock RNase inhibitor (Thermo Scientific, MA, USA) and Nuclease-free H2O (Thermo 
Scientific, MA, USA)  to complete a volume of 18 µL,  the tubes were incubated at 65⁰C 
for 5 minutes and immediately placed on ice for 5 minutes.     
  In the second step, a reverse transcription master mix (RT mix) was prepared by 
adding 0.05 mM of dNTP Mix, 20 U/reaction of Ribolock RNase inhibitor and 100 
U/reaction of RevertAid H Minus Reverse Transcriptase to a final volume of 2 µL. Also, 
a reverse transcriptase control master mix (Minus RT mix) was prepared with all the 
components of the RT mix, except that Nuclease-free H2O (Thermo Scientific, MA, USA) 
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was used as substitute for RevertAid H Minus Reverse Transcriptase (Thermo Scientific, 
MA, USA) to a final volume of 2 µL.  
 In the third step, after addition of RT and Minus RT samples to the mixtures, the 
tubes were incubated at 42ºC for 60 minutes. In the end of the reaction, the samples 
were incubated at 85ºC for 5 min in order to denature the RT enzyme, thus preventing 
unspecific activity or uncontrolled events.        
 Preparation of standard curve mix samples was made by adding 1 µL of each RT 
sample to a tube and diluting to a final 1/5 concentration with H2O. Subsequent points of 
the standard curve were prepared by sequential 1:1 dilutions.   
 Finally, cDNA samples were diluted 1:20 and aliquots of 80 µL were made. For 
further use, the cDNA aliquots were stored at -20 ºC.  
  
 2.12. Relative quantification of mRNA expression  
  Real-time PCR (qPCR) was used to perform relative quantification of mRNA. For 
each studied mRNA molecule, standard curves were generated from the correlation 
between the amount of starting total mRNA and PCR threshold cycle of graded dilutions 
from a pool of all samples. 
  A StepOne™ Real-Time PCR System (Applied BioSystems, MA, USA) was used 
in qPCR experiments.  
  The qPCR reaction per well (12.5 µL) was performed by mixing 2x Maxima SYBR 
Green qPCR Master Mix (Thermo Scientific, MA, USA), 5 µM of gene-specific primers 
(Table 1) and Nuclease-free H2O (Thermo Scientific, MA, USA) to complete a final 
volume of 9.5 µL before adding 3 µL of cDNA (1:20). Instead of cDNA, Nuclease-free 
H2O (Thermo Scientific, MA, USA) was added as a negative control. The PCR reaction 
components were transferred to the wells in triplicate. The plate was centrifuged at 25ºC 
for 2 minutes at 2000 rpm. Centrifugation was performed to get all the contents at the 
bottom of the wells.
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Table 1. Gene-specific primers sequences and biochemical features. 
Primer Sequence (5’→3’) Size (bp) Tm (°C) GC% 
GAPDH FWD CCATCACCATCTTCCAGGAG 20 54.9 55.0 
GAPDH REV GCATGGACTGTGGTCATGAG 20 55.9 55.0 
MHC FWD  TGGTCACCAACAACCCATACGACT 24 70.2 50.0 
MHC REV TGTCAGCTTGTAGACACCAGCCTT 24 68.0 50.0 
MHC FWD GCCAACACCAACCTGTCCAAGTTC 24 71.4 54.1 
MHC REV  TGCAAAGGCTCCAGGTCTGAGGGC 24 76.8 62.5 
ANP FWD  AGGCAGTCGATTCTGCTTGA 20 65.1 50.0 
ANP REV  CGTGATAGATGAAGGCAGGAAG 22 64.7 50.0 
BNP FWD  TAGCCAGTCTCCAGAGCAATTC 22 64.5 50.0 
BNP REV  TTGGTCCTTCAAGAGCTGTCTC 22 64.7 50.0 
DDR2 FWD  GAAATCTACAAGCGACCTGACAT 23 63.2 43.4 
DDR2 REV GATCATTTCAGAAGACGGAGTTG 23 63.7 43.4 
IGF-1 FWD GAAGTCCCCGTCCCTATCGA 20 67.3 60.0 
IGF-1 REV CCTTCTCCTTTGCAGCTTCG 20 66.2 55.0 
IGF-1R FWD AGTGACTCGGATGGCTTCGTT 21 67.1 52.3 
IGF-1R REV TTTCACAGGAAGCTCGCTCTC 21 65.9 52.3 
AT1R FWD GGCAGCATCGGACTAAATGG 20 66.6 55.0 
AT1R REV CCAGCTCCTGACTTGTCCTTG 21 66.2 57.1 
AT2R FWD AGCCAAGGCCAGATTGAAGA 20 66.0 50.0 
AT2R REV GCCACCAGCAGAAACATTACC 21 65.5 52.3 
   
  The thermal cycling profile of the PCR machine was set-up as shown in Table 2. 
Reactions were run for 45 cycles and after that, the amplified PCR products were 
routinely subjected to melting curve analysis (60-95ºC) to verify specificity of the 
amplification. Afterwards, gel electrophoresis 1% (w/v) was performed to exclude primer-
dimer formation and assess the purity of the amplification product. 
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Table 2. Thermal cycler profile. 
Temperature (°C) Time (minutes:seconds) 
95 05:00 
95 00:30 
60 01:00 
95 00:15 
60 01:00 
   
 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels were 
similar in all experimental groups, which enabled the use of this gene as an internal 
control. Results of mRNA quantification are expressed in an arbitrary unit (AU) after 
normalization for GAPDH. 
  Fold changes were determined using the standard curve method as described by 
others (Larionov, Krause, & Miller, 2005). 
 
 2.13. Statistics 
 All results are expressed as mean ± standard error of the means (SEM) for the 
indicated number of determinations. Student's unpaired t-test was applied to data 
regarding distance and total time run during chronic exercise training and catecholamine 
assays. Hemodynamic results were assessed by two-way ANOVA and two-way 
repeated measures ANOVA. Residuals normality was checked by Shapiro-Wilk’s test 
and homogeneity of variances by Levene’s or Box's M test. For the ESPVR and EDPVR 
analysis, volume intercept and scaling constant were included as covariates, 
respectively. All other statistical analysis was performed only by two-way ANOVA and 
log transformation of variables was applied whenever necessary to overcome violation 
of assumptions. When not possible to meet the assumptions at all, a Kruskal-Wallis non 
parametric test was used, and when appropriate, post hoc analysis was performed using 
Newman-Keuls’ test. The comparisons regarding hemodynamic results were made using 
STATISTICA (StatSoft, Inc., OK, USA) software. All other results were assessed by two-
way ANOVA (BP and HR, morphometric and echocardiographic analysis, plasma BNP, 
and qPCR). All other comparisons were made using GraphPad Prism statistics software 
package (GraphPad Software Inc., CA, USA). A statistical significant difference was set 
at P<0.05. 
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3. Results 
 
 3.1. Genotyping 
 The presence of the Pnmt-KO (mutant) allele was verified by PCR-based 
genotyping. Amplification reactions yielded products of 200 and 160 bp for the WT and 
Pnmt-KO alleles, respectively (Figure 6). 
 
 
 
Figure 6. PCR amplification of the Pnmt gene in ear samples. The PCR products and ladder were separated in a 1.0 % 
agarose gel, photographed and representative examples are shown. The DNA fragments expected for the wild-type (WT, 
200 bp), heterozygous (HET, 200 bp and 160 bp) and Pnmt-KO (mutant, 160 bp) mice are indicated.  
 
 3.2. Catecholamines 
 EPI levels in AGs were vestigial in Pnmt-KO when compared with WT mice 
(Figure 7A). On the contrary, NE levels in AGs were significantly higher in Pnmt-KO than 
in WT animals (Figure 7B). 
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Figure 7. Quantification of A) EPI and B) NE levels in adrenal gland (AG) in WT and Pnmt-KO mice. Values are means ± 
SEM of 6-10 animals per group. WT, wild-type; Pnmt-KO, Phenylethanolamine-N-methyltransferase-knockout.  
*Significantly different from correspondent values in WT mice (P < 0.05).  
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 Immediately after acute exercise training, NE levels in AGs were higher in trained 
compared to sedentary WT mice (Table 3). Also, no significant differences were found 
in EPI levels in AGs between acute trained and sedentary WT mice (Table 3). 
 
Table 3. Quantification of EPI and NE in adrenal glands in sedentary and acute exercise trained WT mice. 
  WT WT acute ex 
EPI 
Adrenal Gland 
(nmol/AG) 
12.80 ± 1.29 12.91 ± 0.73 
NE 
Adrenal Gland 
(nmol/AG) 
7.17 ± 0.55 9.73 ± 0.62* 
Values are means ± SEM of 6-7 animals per group. WT, wild-type; WT acute ex, acute exercise trained wild-type; EPI, 
epinephrine; NE, norepinephrine; AG, adrenal gland. * Significantly different from correspondent values in WT mice (P < 
0.05).       
 
 3.3. Distance and total time run during chronic exercise training 
 No differences were found in distance travelled (Figure 8A) and running time 
duration (Figure 8B) between chronic exercise trained Pnmt-KO and WT mice. 
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Figure 8. A) Distance travelled and B) running time duration in chronic exercise trained WT and Pnmt-KO mice. Values 
are means ± SEM of 5-8 animals per group. WT ex, chronic exercise trained wild-type; Pnmt-KO ex, chronic exercise 
trained Phenylethanolamine-N-methyltransferase-knockout. 
 
 3.4. Blood pressure and heart rate 
 No differences were observed in SBP (Figure 9A), DBP (Figure 9B) and HR 
(Figure 9C) between sedentary Pnmt-KO and WT mice. However, SBP was significantly 
increased in trained Pnmt-KO when compared to trained WT mice (Figure 9A). 
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Figure 9. A) Systolic (SBP) and B) diastolic (DBP) blood pressure (BP), and C) heart rate (HR) in sedentary and chronic 
exercise trained WT and Pnmt-KO mice. Values are means ± SEM of 5 animals per group. WT ex, chronic exercise trained 
wild-type; Pnmt-KO, Phenylethanolamine-N-methyltransferase-knockout; Pnmt-KO ex, chronic exercise trained 
Phenylethanolamine-N-methyltransferase-knockout. ‡Significantly different from correspondent values in WT ex mice (P 
< 0.05).  
 
 3.5. Morphometric parameters 
 In sedentary Pnmt-KO mice, BW, HW/BW and LVW/BW were significantly lower 
than in sedentary WT mice. Moreover, in trained WT mice, only IVSW/BW was 
significantly higher than in sedentary WT animals. BW, HW/BW, LVW/BW and IVSW/BW 
were significantly increased in trained Pnmt-KO compared with sedentary Pnmt-KO 
mice. Trained Pnmt-KO mice also showed a significant increase in HW/BW compared to 
trained WT mice, and no differences in BW were observed between both groups. 
Additionally, no significant differences were found in RVW/BW, GW/BW and tibia length 
between all groups (Table 4). 
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Table 4. Morphometric parameters for sedentary and chronic exercise trained WT and Pnmt-KO mice. 
 WT Pnmt-KO WT ex Pnmt-KO ex 
BW, g 29.0 ± 0.5 27.2 ± 0.3* 29.9 ± 0.8 30.5 ± 1.4† 
HW/BW, mg/g 5.73 ± 0.12 5.01 ± 0.15* 5.75 ± 0.23 6.64 ± 0.64†‡ 
LVW/BW, mg/g 2.36 ± 0.10 1.83 ± 0.04* 2.18 ± 0.07 2.26 ± 0.12† 
IVSW/BW, mg/g 1.28 ± 0.06 1.31 ± 0.05 1.57 ± 0.08* 1.82 ± 0.21† 
RVW/BW, mg/g 0.90 ± 0.04 0.90 ± 0.05 0.94 ± 0.06 1.03 ± 0.20 
GW/BW, mg/g 4.97 ± 0.24 5.47 ± 0.21 5.07 ± 0.27 4.64 ± 0.31 
Tibia length, cm 18.4 ± 0.1 18.2 ± 0.1 18.6 ± 0.3 18.9 ± 0.3 
 
Values are means ± SEM of 5-12 animals per group. WT, wild-type; WT ex, chronic exercise trained wild-type; Pnmt-KO, 
Phenylethanolamine-N-methyltransferase-knockout; Pnmt-KO ex, chronic exercise trained Phenylethanolamine-N-
methyltransferase-knockout. BW, body weight; HW/BW, ratio of heart weight to body weight; LVW/BW, ratio of left 
ventricular weight to body weight; IVSW/BW, ratio of interventricular septum weight to body weight; RVW/BW, ratio of 
right ventricular weight to body weight; GW/BW, ratio of gastrocnemius muscle weight to body weight. * Significantly 
different from correspondent values in WT mice (P < 0.05). †Significantly different from correspondent values in Pnmt-KO 
mice (P < 0.05). ‡Significantly different from correspondent values in WT ex mice (P < 0.05).  
 
 3.6. Echocardiographic measurements 
 Regarding sedentary groups, even though there was no change in LV mass 
(LVMi) (Figure 10A), the ratio of LV end-diastolic posterior wall thickness to LV end-
diastolic internal dimension (LVPWd/LVIDd) (Figure 10D) was significantly higher in 
Pnmt-KO compared to WT mice. In contrast, in Pnmt-KO mice, LV end-diastolic internal 
dimension (LVIDd) and indexed LV end-diastolic volume (LVEDVi) were significantly 
lower than in WT mice (Table 5). Moreover, in sedentary Pnmt-KO mice, indexed stroke 
volume (SVi) and cardiac index (CI) were decreased, with no changes in other cardiac 
contractility parameters (FS, EF, S’ and IVA) (Table 5). Echocardiographic parameters 
of diastolic function (E/E’ and E/A) also showed no changes between sedentary mice 
(Table 5).           
 In chronic exercise, it was observed in WT mice a significantly increased LV mass 
(LVMi) (Figure 10A), interventricular end-diastolic septal thickness (IVSd) (Table 5), LV 
posterior wall thickness (LVPWd (Figure 10B) and LVPWs (Figure 10C)), and 
LVPWd/LVIDd (Figure 10D), without significant differences in LV volume (LVIDd, LVIDs, 
LVEDVi and LVESVi) when compared with sedentary WT mice (Table 5). Furthermore, 
when compared with sedentary WT mice, there were no changes in systolic (FS, EF, S´, 
IVA, SVi, and CI) and diastolic function (E/E’ and E/A) indexes in trained WT mice (Table 
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5).          
 Moreover, in trained Pnmt-KO mice, LV mass (LVMi) (Figure 10A), LV posterior 
wall thickness (LVPWd (Figure 10B) and LVPWs (Figure 10C), LV epicardial area 
(LVEpiAd and LVEpiAs) and interventricular septal thickness (IVSd and IVSs) were 
significantly higher compared with sedentary Pnmt-KO mice (Table 5). Also, LV volume 
(LVIDd and LVEDVi) was significantly higher in trained Pnmt-KO mice compared with 
sedentary Pnmt-KO mice (Table 5). Additionally, SVi and CI increased in trained Pnmt-
KO mice, with no differences in other systolic function parameters (FS, EF, S’ and IVA) 
when compared with sedentary Pnmt-KO mice (Table 5). Parameters of diastolic function 
(E/E’ and E/A) showed no changes between these groups (Table 5).    
 Furthermore, in trained Pnmt-KO mice, a significantly increase was found in LV 
mass (LVMi) (Figure 10A), LV posterior wall thickness (LVPWd (Figure 10B) and LVPWs 
(Figure 10C)), and LV epicardial area (LVEpiAd and LVEpiAs), without significant 
differences in LV volume (LVIDd, LVIDs, LVEDVi and LVESVi) when compared with 
trained WT mice (Table 5). Also, cardiac contractility (FS, EF, S´, IVA, SVi, and CI) and 
relaxation (E/E’ and E/A) parameters did not differ between these groups (Table 5). 
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Table 5. Echocardiographic parameters in sedentary and chronic exercise trained WT and Pnmt-KO mice. 
 WT Pnmt-KO WT ex Pnmt-KO ex 
LVEndoAd, mm2 10.1 ± 0.8 8.4 ± 0.6 9.4 ± 0.6 9.3 ± 1.2 
LVEndoAs, mm2  5.1 ± 0.4 4.7 ± 0.6 4.4 ± 0.4 4.7 ± 0.4 
LVEpiAd, mm2  21.6 ± 0.6 19.6 ± 0.4 22.1 ± 0.8 28.1 ± 1.2†‡ 
LVEpiAs, mm2 17.9 ± 0.7 16.0 ± 0.7 18.8 ± 0.9 23.0 ± 1.6†‡ 
IVSd, mm 0.46 ± 0.02 0.51 ± 0.03 0.59 ± 0.03* 0.69 ± 0.10† 
IVSs, mm 0.47 ± 0.03 0.49 ± 0.04 0.56 ± 0.05 0.69 ± 0.04† 
LVIDd, mm 2.8 ± 0.1 2.2 ± 0.1* 3.0 ± 0.2 3.2 ± 0.2† 
LVIDs, mm 1.5 ± 0.1 1.1 ± 0.1 1.5 ± 0.2 1.8 ± 0.1 
LVEDVi, µL/cm2 0.66 ± 0.07 0.35 ± 0.03* 0.77 ± 0.11 0.89 ± 0.14† 
LVESVi, µL/cm2 0.12 ± 0.03 0.04 ± 0.01 0.12 ± 0.03 0.18 ± 0.03 
SVi, µL/cm2 0.54 ± 0.05 0.30 ± 0.02* 0.65 ± 0.09 0.71 ± 0.12† 
CI, mL/min/cm2 0.22 ± 0.02 0.11 ± 0.03* 0.32 ± 0.05 0.36 ± 0.08† 
FS, % 49 ± 3 52 ± 2 52 ± 4 43 ± 3 
EF, % 81 ± 2 87 ± 2 86 ± 3 80 ± 3 
S’, cm/s 5.0 ± 0.3 4.9 ± 0.3 4.9 ± 0.2 4.2 ± 0.9 
IVA, m/s2 4.1± 0.4 4.5 ± 0.5 4.5 ± 0.3 3.7 ± 0.9 
E/E’ 15.1 ± 1.43 16.3 ± 1.40 17.0 ± 1.16 20.1 ± 4.30 
E/A 1.50 ± 0.05 1.30 ± 0.03 1.41 ± 0.07 1.29 ± 0.10 
 
Values are means ± SEM of 5–12 animals per group. WT, wild-type; WT ex, chronic exercise trained wild-type; Pnmt-KO, 
Phenylethanolamine-N-methyltransferase-knockout; Pnmt-KO ex, chronic exercise trained Phenylethanolamine-N-
methyltransferase-knockout. LVEndoAd, left ventricular end-diastolic endocardial area; LVEndoAs, left ventricular end-
systolic endocardial area; LVEpiAd, left ventricular end-diastolic epicardial area; LVEpiAs, left ventricular end-systolic 
epicardial area; IVSd, interventricular end-diastolic septal thickness; IVSs, interventricular end-systolic septal thickness; 
LVIDd, left ventricular end-diastolic internal dimension; LVIDs, left ventricular end-systolic internal dimension; LVEDVi, 
indexed left ventricular end-diastolic volume; LVESVi, indexed left ventricular end-systolic volume; SVi, indexed stroke 
volume; CI, cardiac index; FS, fractional shortening; EF, ejection fraction; S’, maximum systolic tissue Doppler velocity at 
the lateral mitral annulus; IVA, isovolumetric acceleration; E/E’, ratio between peak velocity of early filling in transmitral 
flow pulsed-wave Doppler and maximum velocity of early diastolic myocardial motion at the lateral mitral annulus; E/A, 
ratio between peak velocity of early filling to peak velocity of late filling in transmitral flow pulsed-wave Doppler. 
*Significantly different from correspondent values in WT mice (P < 0.05). †Significantly different from correspondent values 
in Pnmt-KO mice (P < 0.05). ‡Significantly different from correspondent values in WT ex mice (P < 0.05).  
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Figure 10. A) Left ventricular mass indexed for body surface area (LVMi), B) left ventricular end-diastolic posterior wall 
thickness (LVPWd), C) left ventricular end-systolic posterior wall thickness (LVPWs) and D) ratio of left ventricular end-
diastolic posterior wall thickness to left ventricular end-diastolic internal dimension (LVPWd/LVIDd) echocardiographic 
measurements in sedentary and chronic exercise trained WT and Pnmt-KO mice. Values are means ± SEM of 5–12 
animals per group. WT, wild-type; WT ex, chronic exercise trained wild-type; Pnmt-KO, Phenylethanolamine-N-
methyltransferase-knockout; Pnmt-KO ex, chronic exercise trained Phenylethanolamine-N-methyltransferase-knockout. 
*Significantly different from correspondent values in WT mice (P < 0.05). †Significantly different from correspondent values 
in Pnmt-KO mice (P < 0.05). ‡Significantly different from correspondent values in WT ex mice (P < 0.05).  
 
 3.7. Hemodynamic measurements 
 In sedentary mice, at baseline conditions, LVEDVi (Table 6) and CI (Figure 11B) 
were significantly lower in Pnmt-KO compared to WT mice. Compared to basal 
parameters, acute 1-adrenergic stimulation with dobutamine decreased maximum 
pressure (Pmax) and LVESVi in sedentary Pnmt-KO mice and did not decreased both in 
sedentary WT mice (Table 6).        
 At baseline conditions, trained WT mice showed a significantly increase in Pmax 
in comparison to sedentary WT mice (Table 6). Compared to basal parameters, acute 
1-adrenergic stimulation with dobutamine increased PRSW, LVESVi, SVi LVEDVi, VVCi, 
(Table 6) and CI (Figure 11B) in trained WT, and not in sedentary WT mice.  
 Moreover, at baseline conditions, trained Pnmt-KO mice showed a significant 
increase in Pmax, LVEDVi (Table 6) and CI (Figure 11B) compared with sedentary Pnmt-
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KO mice. Compared to basal parameters, acute 1-adrenergic stimulation with 
dobutamine decreased LVESVi (Table 6) and increased EF (Figure 11A) in sedentary 
Pnmt-KO, and not in trained Pnmt-KO mice (Table 6).     
 No differences were observed in baseline conditions between trained WT and 
Pnmt-KO mice (Table 6). Compared to basal parameters, acute 1-adrenergic 
stimulation with dobutamine increased SVi, LVEDVi, VVCi, (Table 6), EF (Figure 11A) 
and CI (Figure 11B) in trained WT mice, and did not increase in trained Pnmt-KO mice. 
In addition, acute 1-adrenergic stimulation with dobutamine, compared to basal 
parameters, decreased LVESVi in trained WT mice, and did not decrease in trained 
Pnmt-KO mice (Table 6).          
 Compared to basal parameters, acute 1-adrenergic stimulation with dobutamine 
decreased arterial elastance (Eai) in all groups (Table 6).   
 Moreover, after acute 1-adrenergic stimulation with dobutamine, no significant 
differences were found in EESi, i and EDP in all groups (Table 6). 
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Figure 11. A) Ejection fraction (EF) and B) cardiac index (CI) hemodynamic measurements, at baseline and after 
dobutamine (β1-adrenoceptor agonist) perfusion, in sedentary and chronic exercise trained WT and Pnmt-KO mice. Data 
are means ± SEM of 5-12 animals per group. WT, wild-type; WT ex, chronic exercise trained wild-type; Pnmt-KO, 
Phenylethanolamine-N-methyltransferase-knockout; Pnmt-KO ex, chronic exercise trained Phenylethanolamine-N-
methyltransferase-knockout. #Significantly different from correspondent values in respective baseline (P < 0.05). 
*Significantly different from correspondent values in WT mice (P < 0.05). †Significantly different from correspondent values 
in Pnmt-KO mice (P < 0.05).  
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Table 6. Hemodynamic parameters at baseline and after dobutamine (β1-adrenoceptor agonist) perfusion in sedentary 
and chronic exercise trained WT and Pnmt-KO mice. 
 
 
 
 
WT Pnmt-KO WT ex Pnmt-KO ex 
Pmax, mmHg 
Baseline 89.5 ± 3.2 90.4 ± 2.6 102.9 ± 1.5* 103.8 ± 5.2† 
Dobutamine 88.2 ± 4.4 80.5 ± 2.9# 100.1 ± 2.6 98.3 ± 4.6 
EESi, mmHg/L/cm2 
Baseline 132.9 ± 11.1 168.1 ± 22.9 149.1 ± 15.4 160.5 ± 28.8 
Dobutamine 206.0 ± 40.2 218.5 ± 56.0 240.5 ± 20.1 183.2 ± 30.7 
PRSW, mmHg 
Baseline 59.4 ± 7.2 61.5 ± 7.4 36.9 ± 6.5 59.1 ± 6.4 
Dobutamine 75.9 ± 10.6 68.5 ± 6.9 85.0 ±10.3# 102.1 ± 5.3# 
LVESVi, µL/cm2 
Baseline 0.31 ± 0.03 0.23 ± 0.05 0.48 ± 0.08 0.43 ± 0.08 
Dobutamine 0.27 ± 0.03 0.18 ± 0.03# 0.39 ± 0.06# 0.41 ± 0.09 
SVi, µL/cm2 
Baseline 0.51 ± 0.04 0.38 ± 0.04 0.45 ± 0.02 0.47 ± 0.05 
Dobutamine 0.62 ± 0.04 0.45 ± 0.07 0.65 ± 0.07# 0.53 ± 0.05 
I, L/cm2 
Baseline 6.5 ± 0.8 7.1 ± 1.3 4.4 ± 0.4 7.3 ± 2.2 
Dobutamine 5.9 ± 0.70 7.2 ± 0.8 3.6 ± 0.2 6.7 ± 2.1 
LVEDVi, µL/cm2 
Baseline 0.79 ± 0.04 0.56 ± 0.07* 0.88 ± 0.08 0.84 ± 0.10† 
Dobutamine 0.86 ± 0.05 0.60 ± 0.10 0.99 ± 0.09# 0.86 ± 0.09 
EDP, mmHg 
Baseline 6.3 ± 0.8 7.2 ± 0.6 5.4 ± 0.9 4.2 ± 0.3 
Dobutamine 4.6 ± 0.4 5.3 ± 1.5 3.5 ± 0.4 3.9 ± 0.7 
Eai, mmHg/µL/cm2 
Baseline 162.6 ± 13.4 242.9 ± 36.0 217.5 ± 8.0 208.4 ± 24.5 
Dobutamine 122.9 ± 10.3# 186.9 ± 33.4# 139.4 ± 17.8# 163.7 ± 28.8# 
VVCi 
Baseline 0.9 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 0.8 ± 0.1 
Dobutamine 1.7 ± 0.4 1.1 ± 0.1 1.8 ± 0.2# 1.2 ± 0.3 
 
Values are means ± SEM of 5–12 animals per group. WT, wild-type; WT ex, chronic exercise trained wild-type; Pnmt-KO, 
Phenylethanolamine-N-methyltransferase-knockout; Pnmt-KO ex, chronic exercise trained Phenylethanolamine-N-
methyltransferase-knockout. Pmax, maximum pressure; EES i, end-systolic elastance derived from end-systolic pressure-
volume relationship; PRSW, preload recruitable stroke work; LVESVi, indexed left ventricular end-systolic volume; SVi, 
indexed stroke volume;i, left ventricular chamber stiffness constant derived from end-diastolic pressure-volume 
relationship; LVEDVi, indexed left ventricular end-diastolic volume; EDP, end-diastolic pressure; Eai, arterial 
elastance index; VVCi, ventricular-vascular coupling index. #Significantly different from correspondent values in respective 
baseline (P < 0.05). *Significantly different from correspondent values in WT mice (P < 0.05). †Significantly different from 
correspondent values in Pnmt-KO mice (P < 0.05). ‡Significantly different from correspondent values in WT ex mice (P < 
0.05). 
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 3.8. Plasma brain natriuretic peptide measurements 
 Plasma BNP concentration was not significant different between sedentary (7.9 
± 3.7 vs 18.5 ± 4.5 pg/mL; n=8-9) and chronic exercise trained (9.9 ± 4.0 vs 12.9 ± 3.4 
pg/mL; n=5-6) Pnmt-KO and WT mice. 
 
 3.9. Cardiac Gene Expression 
 In the LV, mRNA expression of ANP (Figure 12A) and IGF-1 (Figure 12F) was 
significantly increased in trained Pnmt-KO mice when compared to trained WT and to 
sedentary Pnmt-KO mice. No differences were observed in BNP (Figure 12B), MHC 
(Figure 12C), MHC (Figure 12D), DDR2 (Figure 12E), IGF-1R (Figure 12G) and AT1R 
(Figure 12H) mRNA expression between all groups of animals. Also, no significant 
difference was found in the ratio MHC/MHC mRNA expression between sedentary 
(0.8 ± 0.4 vs 0.8 ± 0.3; n=6-7) and chronic exercise trained (1.5 ± 0.3 vs 3.2 ± 1.7; n=5-
6) Pnmt-KO and WT mice. Moreover, regarding mRNA expression of AT2R, there was 
no amplification observed.  
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Figure 12. LV mRNA expression of A) atrial natriuretic peptide (ANP), B) brain natriuretic peptide (BNP), C) -myosin 
heavy chain (MHC), D) -myosin heavy chain (MHC), E) discoidin domain receptor 2 (DDR2); F) insulin-like growth 
factor-1 (IGF-1) ;G) insulin-like growth factor 1 receptor (IGF-1R) and H) angiotensin II type 1 receptor (AT1R) in sedentary 
and chronic exercise trained WT and Pnmt-KO mice. Results are expressed as arbitrary units after normalization for 
GAPDH. Values are means ± SEM of 6-8 animals per group. WT, wild-type; WT ex, chronic exercise trained wild-type; 
Pnmt-KO, Phenylethanolamine-N-methyltransferase-knockout; Pnmt-KO ex, chronic exercise trained 
Phenylethanolamine-N-methyltransferase-knockout. † Significantly different from correspondent values in Pnmt-KO mice 
(P < 0.05). ‡ Significantly different from correspondent values in WT ex mice (P < 0.05).
  
  
FCUP 
Role of epinephrine in cardiovascular function after chronic exercise 
53 
 
4. Discussion and conclusion 
 The present work has successfully assessed that chronic exercise training in 
Pnmt-KO mice resulted in functional cardiovascular adaptations and significant cardiac 
hypertrophy. Also, epinephrine appeared to be important for maintaining a normal BP, 
probably through 2-AR induced vessel relaxation, and preventing LV hypertrophy in 
chronic exercise.          
 In this study, an epinephrine-deficient mouse model in which the EPI-synthesizing 
enzyme Pnmt is knocked out was used (Ebert et al., 2004), and the absence of the 
Pnmt+/+ alele was confirmed by genotyping. Several authors showed that EPI was absent 
in AGs whereas the NE content of the AGs was significantly increased in Pnmt-KO mice 
(Ebert et al., 2004; Bao et al., 2007; Sun et al., 2008; Moreira-Rodrigues et al., 2014). 
The results in the present work were similar. Thus, taken together the results regarding 
genotyping and quantification of catecholamines, it was found that the disruption in the 
PNMT gene abolished its expression, therefore preventing the synthesis of EPI in Pnmt-
KO mice.         
 Immediately after acute exercise training, NE levels in AGs were significantly 
higher in trained compared with sedentary WT mice, possibly in order to support the 
increased heart functioning, vasoconstriction and redistribution of blood to exercising 
muscles, and increased ventilatory needs (Garrett & Kirkendall, 2000). Therefore, it is 
expected that during chronic exercise, the increase of NE in both WT and Pnmt-KO mice 
may be favored. In order to prove this, NE levels should be quantified in AGs of sedentary 
and acute trained Pnmt-KO mice. Acute exercise training did not change EPI levels in 
AGs of WT mice. Since EPI has a short half-life (3- to 5-minutes) (Khan, 2006), this could 
make EPI detection and quantification by RP-HPLC-ED difficult.    
 In sedentary animals, systolic and diastolic BP did not differ and morphometric 
parameters, such as BW, HW/BW and LVW/HW were lower in Pnmt-KO mice. In 
addition, the observed increased ratio of diastolic LV wall thickness to LV cavity 
(LVPWd/LVIDd) and normal LV mass (LVMi), suggests a concentric remodeling of the 
LV of sedentary EPI-deficient Pnmt-KO mice, and this echocardiographic results are 
similar to those previously reported by Bao et al. (2007) (Bao et al., 2007). 
 Furthermore, despite no changes in HR, echocardiographic SVi and 
consequently echocardiographic CI were reduced and this decreased CI may be 
explained by a decreased cardiac filling with a smaller LVEDVi (Bao et al., 2007) in 
sedentary Pnmt-KO mice. LVEDVi may be determined by venous tone and so, the 
reduced echocardiographic LVEDVi in sedentary Pnmt-KO mice is consistent with 
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findings in previous reports (Eckstein & Hamilton, 1957; Trippodo, 1981; Zhang, Weaver, 
Ibeawuchi, & Olson, 1998; Skals, Skovgaard, Abe, & Wang, 2005; Sandblom, Axelsson, 
& Farrell, 2006), that suggest that EPI has effects to constrict veins in vivo, possibly 
through 1 and 2-ARs (Flavahan & Vanhoutte,1987; Faber, 1988; Faber, et al., 1991). 
There were no changes in cardiac contractility echocardiographic parameters, as 
demonstrated by no changes in FS, EF, S’ and IVA in sedentary groups. Also, in 
sedentary mice, diastolic function was similar, as showed by no changes in E/E’ and E/A. 
Thus, in sedentary Pnmt-KO mice, EPI deficiency possibly has no impact on 
cardiovascular functions at rest such as BP and HR.   
 Numerous studies in mice (Calligaris et al., 2013; Cho et al., 1999) have shown 
that cardiac catheterization can be used to measure in vivo responsiveness to 
dobutamine, a 1-AR agonist (Vallet et al., 1991). The increased EF observed may be 
due to dobutamine positive inotropic effect, and the decreased arterial elastance (Eai) 
observed might be due to dobutamine peripheral vasodilatation effect (Ruffolo, 1987). 
 Stress hormones, EPI and NE, may be responsible for many adaptations both at 
rest and during exercise. Previous studies have shown that exercise may induce cardiac 
hypertrophy in mice, namely treadmill exercise (Kemi et al., 2002), voluntary wheel 
training (Allen et al., 2001) and swimming exercise (Kaplan et al., 1994). In the present 
work, in order to access if EPI as a role in the adaptation to chronic exercise, WT and 
EPI-deficient Pnmt-KO mice were subjected to a chronic exercise training protocol. 
Exercise intensity was measured indirectly and no differences in distance and total time 
run were found between all groups, thus suggesting that both Pnmt-KO and WT mice 
adapted to the chronic exercise training protocol similarly.    
 In chronic exercise, a hypertrophied interventricular septum (IVSW/BW) was 
possibly associated with a significantly increased LV posterior wall thickness (LVPWd 
and LVPWs), LVPWd/LVIDd and LV mass (LVMi) in WT mice when compared to 
sedentary WT mice. Taken all together, maybe related with no changes in mRNA 
expression of ANP (marker for pathological cardiac hypertrophy) (Grandi et al., 2004), 
and mRNA expression of DDR2 (marker for cardiac fibroblasts) (Goldsmith et al., 2004), 
suggests a physiological concentric hypertrophy, in an attempt to limit wall stress 
(Gaasch & Zile, 2011), and no cardiac fibrosis in chronic trained WT mice. Furthermore, 
when compared with sedentary WT mice, there were no changes in systolic (FS, EF, S´, 
IVA, SVi and CI) and diastolic function (E/E’ and E/A) echocardiographic indexes in 
trained WT mice.          
 After acute exercise, NE content increased in AGs of WT mice, and it is 
conceivable that it could even be higher in acute trained Pnmt-KO mice, since exercise 
may lead to increased catecholamine levels. Therefore, chronic trained mice may be 
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exposed to high levels of NE in each exercise session. It is known that high levels of NE 
may stimulate renal 1-ARs, increase renin secretion, angiotensin II production and thus 
adrenocortical secretion of aldosterone (Goldstein, 2010). In addition, angiotensin II via 
AT1 receptor is known to contribute to an increase in parameters that lead to an 
increased dilation in the ventricular cavity (McBride, 2006).    
 When compared with sedentary Pnmt-KO mice, a hypertrophied heart (in 
particular IVS/BW and LVW/BW) perhaps related with an increased LV mass (LVMi), LV 
wall thickness (LVPWd and LVPWs), LV internal volume (LVIDd) and mRNA expression 
of IGF-1 (Wahlander, Isgaard, Jennische, & Friberg, 1992; Donohue et al., 1994) and 
ANP and no changes in mRNA expression of DDR2, may be associated with augmented 
NE levels that, by stimulating 1-ARs, could increase angiotensin II production, possibly 
contributing to a thick and dilated concentric LV hypertrophy in chronic trained Pnmt-KO 
mice, which may be pathologic, and no cardiac fibrosis. Even though it is just a 
hypothesis, since there were no differences in mRNA expression of AT1R and no 
amplification of AT2R, angiotensin II seems not to contribute to LV hypertrophy. In order 
to confirm if the renin-angiotensin-aldosterone system (RAAS) plays a role in LV 
hypertrophy, it would be necessary to evaluate renin, angiotensin II and aldosterone 
levels in plasma and in cardiac tissue of WT and Pnmt-KO mice after chronic exercise. 
 Although there was no alteration in echocardiographic myocardial contractility 
(FS, EF, S’ and IVA) and indexes of diastolic function (E/E’ and E/A), chronic exercise 
training led to an increased echocardiographic and hemodynamic preload (LVEDVi) in 
Pnmt-KO mice, possibly due to an increased venous return, which is increased maybe 
as a result of a combination of an increase in sympathetic activity to veins and the use 
of skeletal muscle and respiratory muscle pumps (Kay & Evans, 2014). This increase in 
venous return may lead to an increase in cardiac muscle fiber stretch, thus possibly 
increasing echocardiographic stroke volume (SVi) and consequently cardiac index (CI) 
in trained Pnmt-KO when compared to sedentary Pnmt-KO mice, suggesting an 
improvement in systolic function and therefore functional cardiovascular adaptations with 
chronic exercise in EPI-deficient Pnmt-KO mice.      
 In this work, after chronic exercise, a significant increase in systolic BP was 
observed in Pnmt-KO when compared with WT mice, possibly suggesting that EPI may 
be required to prevent BP overshoot during exercise and to maintain a normal BP, 
probably through β2-AR induced vasodilation. In fact, a previous study in our group 
showed that 2-AR induced vasodilation in Pnmt-KO mice is impaired (Moreira-
Rodrigues et al., 2014). Therefore, in Pnmt-KO when compared with WT mice, chronic 
exercise, maybe associated with an increase in systolic BP, led to an hypertrophied heart 
(HW/BW), an increased LV mass (LVMi), LV wall thickness (LVPWd and LVPWs) and 
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mRNA expression of IGF-1 and ANP, thus possibly stimulating a concentric hypertrophic 
response, in an attempt to normalize the elevated LV wall stress (Alpert et al., 1989; 
Grossman et al., 1975; Hood et al., 1968). These adaptations may protect against the 
development of full pathological cardiac hypertrophy (Kehat & Molkentin, 2010) and 
prevent a further increase in BP via the vasodilatory and natriuretic effects of ANP 
(Woodard & Rosado, 2008) in trained Pnmt-KO mice. Moreover, hypertrophy was not 
associated with cardiac fibrosis because no changes in mRNA expression of DDR2 were 
observed in trained Pnmt-KO when compared with trained WT.    
 Furthermore, after acute 1-adrenergic stimulation with dobutamine, trained 
Pnmt-KO mice did not had any changes in EF, CI, LVESVi, SVi, LVEDVi and VVCi, 
possibly suggesting that EPI deficiency and chronic exercise may lead to these animals 
not to react to dobutamine stress in the same way as trained WT mice. Taken together 
all these observations, concentric hypertrophy might be in an initial pathologic stage in 
trained Pnmt-KO mice.         
 There are a few limitations associated with the present study that should be 
emphasized. First, this study assessed that Pnmt-KO mice adapted to the chronic 
exercise training protocol similarly to WT mice, however the duration of the protocol and 
lack of motivation led some animals in both groups to give up running during the training. 
Nevertheless, the substantial duration of the exercise stimulus appeared to be sufficient 
for the development of cardiovascular adaptations associated with exercise. 
 Second, because of the hemodynamic effects of the anesthetic agents, 
echocardiographic studies in conscious animals are preferred when possible. However, 
it is difficult to train mice to remain still in the conscious state, and movement and 
excitement all affect arterial pressure (Zhao et al., 2011).     
 Third, because in this study there was not enough plasma in order to conduct 
experiences regarding evaluation of renin, angiotensin II and aldosterone, it would be 
important to repeat the chronic exercise training protocol in order to extract more plasma 
of WT and Pnmt-KO mice.        
 In conclusion, the increased systolic BP in response to exercise appears to be 
associated with LV concentric hypertrophy and no fibrosis in Pnmt-KO mice. Also, acute 
1-adrenergic stimulation with dobutamine did not led to any changes in EF, LVEDVi and 
CI in trained Pnmt-KO contrary to trained WT, altogether suggesting a possible initial 
pathological concentric hypertrophy stage with chronic exercise in Pnmt-KO mice. 
Therefore, EPI appears to be essential for maintaining a normal BP, probably through 
β2-AR induced vasodilatation, thus preventing LV hypertrophy during chronic exercise.
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 In the future, because the presence of mRNA transcripts alone does not prove 
similar regulation of a translated product, a Western blot analysis should be made in 
order to confirm if the increased LV IGF-1 and ANP transcripts are translated into a 
protein in chronic trained Pnmt-KO mice.        
 Moreover, in order to evaluate if acute exercise changes NE and EPI levels in 
Pnmt-KO mice, these catecholamines would have to be quantified in AGs and plasma 
by RP-HPLC-ED.         
 In order to confirm if the renin-angiotensin-aldosterone system (RAAS) plays a role 
in LV hypertrophy, it would be necessary to evaluate by RP-HPLC-ED, renin, angiotensin 
II and aldosterone levels in plasma and in cardiac tissue of WT and Pnmt-KO mice after 
chronic exercise.         
 Cardiac myocytes are presumed to enlarge with LV hypertrophy (Tracy & Sander, 
2011). So, assessments of cardiomyocyte number (by enzymatic disaggregation and 
direct cell counting (Naqvi et al., 2014)), length and width (by histology (Coelho-Filho et 
al., 2013)) in WT and Pnmt-KO mice would be of interest in order to confirm the type of 
cardiac hypertrophy.           
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